Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures

Occupational Medicine

Volumn 54, Issue 6, 2004, Pages 408-418

  Baines, Cornelia Johanna ^a   McKeown Eyssen, Gail Elizabeth ^a   Riley, Nicole ^a   Cole, David Edward C ^a   Marshall, Lynn ^a   Loescher, Barry ^a   Jazmaji, Vartouhi ^a  

^a NONE   (Canada)

Author keywords

Chemical intolerance; Environment; Environmental intolerance; Hypersensitivity; MCS; Multiple chemical sensitivity; Olfaction; Unexplained symptoms

Indexed keywords

1,2,3 TRIMETHYLBENZENE; 1,3,5 TRIMETHYLBENZENE; ALANINE AMINOTRANSFERASE; CHLOROFORM; CYANOCOBALAMIN; ETHYLBENZENE; FOLIC ACID; HEMOGLOBIN; HEXANE; HOMOCYSTEINE; META XYLENE; PARA XYLENE; PENTANE; PYRIDOXINE; THYROTROPIN; VOLATILE ORGANIC COMPOUND;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CASE CONTROL STUDY; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLIC ACID BLOOD LEVEL; HEALTH STATUS; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOPATHOGENESIS; LABORATORY TEST; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIPLE CHEMICAL SENSITIVITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCIBILITY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; URBAN POPULATION; VALIDATION PROCESS; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY;

ADULT; ALKANES; BENZENE DERIVATIVES; CASE-CONTROL STUDIES; CHLOROFORM; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FEMALE; FOLIC ACID; HEMATOLOGIC TESTS; HEMOGLOBINS; HOMOCYSTEINE; HUMANS; HYDROCARBONS; MIDDLE AGED; MULTIPLE CHEMICAL SENSITIVITY; VITAMIN B 12; VITAMIN B 6; VITAMINS;

EID: 4644252701     PISSN: 09627480     EISSN: None     Source Type: Journal    
DOI: 10.1093/occmed/kqh083     Document Type: Article

References (46)

1. Ashford NA, Miller CS. Chemical Exposures - Low Levels and High Stakes, 2nd edn. New York: Van Nostrand Reinhold, 1998; 173.
2. American Academy Allergy, Asthma, and Immunology. Idiopathic environmental intolerances. J Allergy Clin Immunol 1999;103:36-40 [position statement].
3. Kipen HM, Fiedler N. Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge. Environ Health Perspect 2002;110(Suppl.):597-599.
4. Cullen M. The worker with multiple chemical sensitivities: an overview. In: Cullen M, ed. Workers with Multiple Chemical Sensitivities. Philadelphia, PA: Hanley & Belfus, 1987;655-662.
5. Miller CS. Toxicant-induced loss of tolerance - an emerging theory of disease? Environ Health Perspect 1977;105:445-453.
6. Stewart DE, Raskin J. Psychiatric assessment of patients with '20th Century Disease' ('Total Allergy Syndrome'). Can Med Assoc J 1985;133:1001-1006.
7. Sparks PJ, Daniell W, Black DW, et al. Multiple chemical sensitivity syndrome: a clinical perspective. 1. Case definition, theories of pathogenesis and research needs. Occup Med 1994;36:718-730.
8. Leznoff A. Multiple chemical sensitivity: myth or reality. Pract Allergy Immunol 1993;8:48-52.
9. Poonai N, Antony MM, Binkley KE, et al. Carbon dioxide inhalation challenges in idiopathic environmental intolerance. J Allergy Clin Immunol 2000;105:358-363.
10. Tarlo SM, Poonai N, Binkley K, Antony MM, Swinson RP. Responses to panic induction procedures in subjects with multiple chemical sensitivity/ideopathic environmental intolerance: Understanding the relationship with panic disorder. Environ Health Perspect 2002;110(Suppl. 4):669-671.
11. Rea W. Environmentally triggered small vessel vasculitis. Ann Allergy 1977;38:245-251.
12. Levin A, Byers V. Environmental illness: a disorder of immune regulation. In: Cullen M, ed. Workers with Multiple Chemical Sensitivities. Philadelphia, PA: Hanley & Belfus, 1987;669-682.
13. Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. Occup Med 1992;34:529-538.
14. Report of Multiple Chemical Sensitivities (MCS) Workshop. Berlin: International Programme on Chemical Safety, 1996;1-36.
15. Meggs WJ, Neurogenic inflammation and sensitivity of environmental chemicals. Env Health Perspect 1993; 101:234-238.
16. Bell I R, Baldwin DM, Russek LGS, et al. Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: support for a neural sensitization model. J Women's Health 1998;7:1135-1147.
17. Sanico AM, Stanisz AM, Gleeson TD, et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000;161:1631-1635.
18. Meggs WJ. Mechanisms of allergy and chemical sensitivity. Toxicol Ind Health 1999;15:331-338.
19. Green GJ, Kipen HM. The vomeronasal organ and chemical sensitivity: a hypothesis. Environ Health Perspect 2002;110(Suppl. 4):655-661.
20. McKeown-Eyssen GE, Baines CJ, Marshall LM, et al. Multiple Chemical Sensitivity: discriminant validity of case definitions. Arch Environ Health 2001;56:406-412.
21. Meggs WJ, Dunn KA, Bloch RM, Goodman PE, Davidoff AL. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health 1996;51:275-282.
22. Dybing E, Soderlund EJ. Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors. Regul Toxicol Pharmacol 1999;30:527-530.
23. Anthony H, Birtwhistle S, Eaton K, et al. Environmental Medicine in Clinical Practice. Southampton: BSAENM Publications, 1997; 276.
24. Rosenstock L, Cullen MR. Textbook of Clinical Occupational and Environmental Medicine. Philadelphia, PA: WB. Saunders, 1994; 443-444.
25. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000;51:337-375.
26. Rall LC, Meydani SN. Vitamin B6 and immune competence. Nutrit Rev 1993;51:217-225.
27. Thomson GM, Day JH, Evers S, et al. Report of the Ad Hoc Committee on Environmental Hypersensitivity Disorders. Toronto: Ontario Ministry of Health, 1985; 17-18.
28. National Research Council, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: National Academy Press, 1992; 5-7.
29. Ashford NA, Miller CS. Case definitions for multiple chemical sensitivity. In: National Research Council, Board on Environmental Studies and Toxicology, Commission on Life Sciences. Multiple Chemical Sensitivities: Addendum to Biologic Markers in Immunotoxicology. Washington, DC: National Academy Press, 1992; 43.
30. Randolph TG. Ecologic orientation in medicine: comprehensive environmental control in diagnosis and therapy. Ann Allergy 1965;23:11-22.
31. Nethercott JR, Davidoff LL, Curbow B, et al. Multiple Chemical Sensitivities Syndrome: toward a working case definition. Arch Environ Health 1993;48:19-26.
32. McKeown-Eyssen GE, Sokoloff ER, Jazmaji V, et al. Reproducibility of the University of Toronto self-administered questionnaire used to assess environmental sensitivity. Am J Epidem 2000;151:1216-1222.
33. Tobit J. Estimation of relationships for limited dependent variables. Econometrica 1958;26:24-36.
34. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
35. SAS Institute Inc. SAS/STAT ®, Users' Guide, version 6, 4th edn, vol. 2. Cary, NC: SAS Institute Inc, 1989.
36. Hu H, Stern A, Rotnitzky A, Schlesinger L, Proctor S, Wolfe J. Development of a brief questionnaire for screening for multiple chemical sensitivity syndrome. Toxicol Indust Hlth 1999;15:582-588.
37. Tietz NW, ed. Clinical Guide to Laboratory Tests, 3rd edn. Philadelphia, PA: WB. Saunders, 1995.
38. Black PH. Psychoneuroimmunology: brain and immunity. Scient Am Sci Med 1995;2:16-25.
39. Klee GG. Cobalamine and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate. Clin Chem 2000;46:1277-1283.
40. Nilsson K, Gustafson L, Hultberg B. The plasma homocysteine concentration is better than that of serum methylmalonic acid as a marker for socio-psychological performance in a psychiatro-geriatric population. Clin Chem 2000;46:691-696.
41. Ray TG, Cole DEC, Boss SC. An Ontario-wide study of vitamin B12, serum folate and red cell folate levels in relation to plasma homocysteine: is it a preventable public health issue on the rise? Clin Biochem 2000;3:337-343.
42. Research Triangle Institute. Toxicological Profile for Chloroform (Update). Washington, DC: US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, 1997.
43. Wallace LA. The TEAM study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ Res 1987;43:290-307.
44. Cole CM. Assessment and Remediation of Petroleum Contaminated Sites. CRC Press, USA: 1994; 273-277.
45. Clement International Corporation. Toxicological Profile for Styrene. Washington, DC: US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, 1992.
46. Pintus F, Mascia P. Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. Eur J Epidem 1996;12:71-76.